DIABOT
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Jan 2022)
What this means for you
This application is over — abandoned 17 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87831855
- Mark type
- Stylized text
- Filed
- 13 Mar 2018
- Published for opposition
- 16 Oct 2018
- Abandoned
- 17 Jan 2022
- Attorney of record
- Jennifer Lee Taylor
Goods and services
- Class 009 — Scientific and electric apparatus: Computer hardware and software for collecting, receiving, processing, transmitting and displaying medical patient information and data via telecommunication and global computer networks to a central repository for storage and remote access; computer operating systems for medical devices; computer software for use with glucose sensors, namely, software for recording blood test results from a blood glucose monitor, for communicating with other devices, for controlling other medical devices, for functioning as a hypervisor, for providing security functions, and for providing a general purpose computing platform; downloadable computer software application for diabetes monitoring, management and maintenance; computer hardware and networking apparatus for wireless communications systems for medical devices; computer software for wireless communications systems for medical devices, namely, software for transmitting and analysis of medical device data, for providing secure communications, for communicating with other medical devices, for controlling other devices, for transmitting power wirelessly, and for communicating with local networks, mobile networks, and global communication networks; computer hardware, software and firmware for controlling and interconnecting medical devices and mobile communication devices; computer hardware and software hypervisors
- Class 010 — Medical apparatus: Medical apparatus and instruments for diagnosing, monitoring, and treating diabetes; Medical devices for administering drugs, namely, diabetes management devices in the nature of injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical devices, namely, devices used to draw blood for glucose testing and diabetes management
Owner
- Rearden LLC, Mountain View, CA, US
- Rearden LLC, Mountain View, CA, US
Prosecution history
- 18 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2021 — SOU EXTENSION 5 GRANTED
- 25 May 2021 — SOU EXTENSION 5 FILED
- 01 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 May 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2020 — SOU EXTENSION 4 GRANTED
- 21 Oct 2020 — SOU EXTENSION 4 FILED
- 21 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Apr 2020 — SOU EXTENSION 3 GRANTED
- 09 Apr 2020 — SOU EXTENSION 3 FILED
- 09 Apr 2020 — SOU TEAS EXTENSION RECEIVED